Denali Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2018 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Denali Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2018 to 2023.
  • Denali Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.63 USD/shares, a 12.5% increase year-over-year.
  • Denali Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.78 USD/shares, a 199% decline year-over-year.
  • Denali Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -1.06 USD/shares, a 59.2% increase from 2022.
  • Denali Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -2.6 USD/shares, a 8.79% decline from 2021.
  • Denali Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -2.39 USD/shares, a 468% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$1.54 +59.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$3 $0 -8.79% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$2 -$3 -468% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $0.65 +$2.72 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$2 -$2 -431% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.